DaVita Stock (NYSE: DVA) stock price, news, charts, stock research, profile.
|Vol / Avg.987.422K / 1.293M||Mkt Cap9.099B|
|Day Range98.950 - 101.900||52 Wk Range69.550 - 116.970|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2023-10-11||Truist Securities||David Macdonald||Maintains||HoldHold||Lowers||115.00||104.00|
|2023-07-13||Truist Securities||David Macdonald||Maintains||HoldHold||Raises||100.00||115.00|
|Ticker||Company||Chg %||Mkt Cap|
|HIMS||Hims & Hers Health||3.93%||1.9B|
You can purchase shares of DaVita (NYSE: DVA) through any online brokerage.
The latest price target for DaVita (NYSE: DVA) was reported by UBS on Friday, November 17, 2023. The analyst firm set a price target for 113.00 expecting DVA to rise to within 12 months (a possible 13.44% upside). 12 analyst firms have reported ratings in the last year.
The stock price for DaVita (NYSE: DVA) is $99.61 last updated Today at November 30, 2023 at 12:00 AM UTC.
There is no dividend information for DaVita.
DaVita’s Q4 earnings are confirmed for Wednesday, February 21, 2024.
There is no upcoming split for DaVita.
DaVita is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.